Literature DB >> 21969335

Dendritic cell dysfunction during primary HIV-1 infection.

Jinghe Huang1, Yue Yang, Maha Al-Mozaini, Patrick S Burke, Jill Beamon, Mary F Carrington, Katherine Seiss, Jennifer Rychert, Eric S Rosenberg, Mathias Lichterfeld, Xu G Yu.   

Abstract

Dendritic cells have critical roles for generating and fine-tuning adaptive immune responses and for regulating immune activity through cytokine secretion. In this study, we analyzed functional properties of dendritic cells in primary human immunodeficiency virus type 1 (HIV-1) infection. We found substantial disarray of the functional properties of myeloid and plasmacytoid dendritic cells in acute HIV-1 infection, which included defective antigen-presenting and cytokine secretion properties and was associated with a distinct surface expression profile of immunomodulatory dendritic cell receptors from the leukocyte immunoglobulin-like receptor family. These data indicate that key functional properties of dendritic cells are compromised during primary HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21969335      PMCID: PMC3192192          DOI: 10.1093/infdis/jir616

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals.

Authors:  Jihed Chehimi; Donald E Campbell; Livio Azzoni; Darlene Bacheller; Emmanouil Papasavvas; Ghassen Jerandi; Karam Mounzer; Jay Kostman; Giorgio Trinchieri; Luis J Montaner
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

Review 2.  The LILR family: modulators of innate and adaptive immune pathways in health and disease.

Authors:  D Brown; J Trowsdale; R Allen
Journal:  Tissue Antigens       Date:  2004-09

3.  Dendritic cells exposed to herpes simplex virus in vivo do not produce IFN-alpha after rechallenge with virus in vitro and exhibit decreased T cell alloreactivity.

Authors:  Pia Björck
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

4.  SAGE library screening reveals ILT7 as a specific plasmacytoid dendritic cell marker that regulates type I IFN production.

Authors:  Minkwon Cho; Koji Ishida; Jingtao Chen; Jun Ohkawa; Wei Chen; Sahori Namiki; Ayumi Kotaki; Naoko Arai; Ken-ichi Arai; Yumiko Kamogawa-Schifter
Journal:  Int Immunol       Date:  2007-11-28       Impact factor: 4.823

5.  Different subsets of peripheral blood dendritic cells show distinct phenotypic and functional abnormalities in HIV-1 infection.

Authors:  María Almeida; Miguel Cordero; Julia Almeida; Alberto Orfao
Journal:  AIDS       Date:  2005-02-18       Impact factor: 4.177

6.  Evidence of dysregulation of dendritic cells in primary HIV infection.

Authors:  Rachel Lubong Sabado; Meagan O'Brien; Abhignya Subedi; Li Qin; Nan Hu; Elizabeth Taylor; Oliver Dibben; Andrea Stacey; Jacques Fellay; Kevin V Shianna; Frederick Siegal; Michael Shodell; Kokila Shah; Marie Larsson; Jeffrey Lifson; Arthur Nadas; Michael Marmor; Richard Hutt; David Margolis; Donald Garmon; Martin Markowitz; Fred Valentine; Persephone Borrow; Nina Bhardwaj
Journal:  Blood       Date:  2010-08-06       Impact factor: 22.113

7.  Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections.

Authors:  Andrea R Stacey; Philip J Norris; Li Qin; Elizabeth A Haygreen; Elizabeth Taylor; John Heitman; Mila Lebedeva; Allan DeCamp; Dongfeng Li; Douglas Grove; Steven G Self; Persephone Borrow
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

8.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

9.  Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection.

Authors:  Eberhard W Fiebig; David J Wright; Bhupat D Rawal; Patricia E Garrett; Richard T Schumacher; Lorraine Peddada; Charles Heldebrant; Richard Smith; Andrew Conrad; Steven H Kleinman; Michael P Busch
Journal:  AIDS       Date:  2003-09-05       Impact factor: 4.177

10.  Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro.

Authors:  John C Tilton; Maura M Manion; Marlise R Luskin; Alison J Johnson; Andy A Patamawenu; Claire W Hallahan; Nancy A Cogliano-Shutta; Joann M Mican; Richard T Davey; Shyam Kottilil; Jeffrey D Lifson; Julia A Metcalf; Richard A Lempicki; Mark Connors
Journal:  J Virol       Date:  2008-02-06       Impact factor: 5.103

View more
  21 in total

1.  Early SIV and HIV infection promotes the LILRB2/MHC-I inhibitory axis in cDCs.

Authors:  Lamine Alaoui; Gustavo Palomino; Sandy Zurawski; Gerard Zurawski; Sixtine Coindre; Nathalie Dereuddre-Bosquet; Camille Lecuroux; Cecile Goujard; Bruno Vaslin; Christine Bourgeois; Pierre Roques; Roger Le Grand; Olivier Lambotte; Benoit Favier
Journal:  Cell Mol Life Sci       Date:  2017-11-13       Impact factor: 9.261

2.  Macrophages and Myeloid Dendritic Cells Lose T Cell-Stimulating Function in Simian Immunodeficiency Virus Infection Associated with Diminished IL-12 and IFN-α Production.

Authors:  Elizabeth R Wonderlich; Wen-Chi Wu; Daniel P Normolle; Simon M Barratt-Boyes
Journal:  J Immunol       Date:  2015-08-21       Impact factor: 5.422

Review 3.  Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?

Authors:  A Saez-Cirion; B Jacquelin; F Barré-Sinoussi; M Müller-Trutwin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-05-12       Impact factor: 6.237

4.  Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruption.

Authors:  Julie L Mitchell; Hiroshi Takata; Roshell Muir; Donn J Colby; Eugène Kroon; Trevor A Crowell; Carlo Sacdalan; Suteeraporn Pinyakorn; Suwanna Puttamaswin; Khunthalee Benjapornpong; Rapee Trichavaroj; Randall L Tressler; Lawrence Fox; Victoria R Polonis; Diane L Bolton; Frank Maldarelli; Sharon R Lewin; Elias K Haddad; Praphan Phanuphak; Merlin L Robb; Nelson L Michael; Mark de Souza; Nittaya Phanuphak; Jintanat Ananworanich; Lydie Trautmann
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

Review 5.  Immunosenescence and hurdles in the clinical management of older HIV-patients.

Authors:  Marco Ripa; Stefania Chiappetta; Giuseppe Tambussi
Journal:  Virulence       Date:  2017-02-21       Impact factor: 5.882

Review 6.  Aging of the human innate immune system in HIV infection.

Authors:  Heidi J Zapata; Albert C Shaw
Journal:  Curr Opin Immunol       Date:  2014-07-02       Impact factor: 7.486

7.  Virus-encoded TLR ligands reveal divergent functional responses of mononuclear phagocytes in pathogenic simian immunodeficiency virus infection.

Authors:  Elizabeth R Wonderlich; Viskam Wijewardana; Xiangdong Liu; Simon M Barratt-Boyes
Journal:  J Immunol       Date:  2013-01-21       Impact factor: 5.422

Review 8.  Dendritic cell dysregulation during HIV-1 infection.

Authors:  Elizabeth Miller; Nina Bhardwaj
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

Review 9.  Immunogenetics of HIV disease.

Authors:  Maureen P Martin; Mary Carrington
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

10.  Differential type 1 interferon-regulated gene expression in the brain during AIDS: interactions with viral diversity and neurovirulence.

Authors:  Maria J Polyak; Pornpun Vivithanaporn; Ferdinand G Maingat; John G Walsh; William Branton; Eric A Cohen; Rick Meeker; Christopher Power
Journal:  FASEB J       Date:  2013-04-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.